Beek, C. van de

bladder patient effect group treatment cancer study epirubicin urology progression water intravesical trial recurrence bacillu calmette-guerin bladder cancer bacillus calmette-guerin intervention baseline symptom result water turnover randomized analysis sylvester intermediate-risk patients volume tumor measurement instillation isovolumetric bladder pressure chemotherapy tract symptoms pressure bladder function function score urine european 6 months eortc stage urine output metastase tract ficial bladder cancer point bacillus ´ calmette-guerin bladder wall thickness intermediate-risk end points turnover survival urothelial number event signi ficant effect control group prostate symptom score month signi prostate treatment groups european organization table animal studies output intervention group ficant death obstruction protocol carcinoma parameter participant isoniazid control disease-speci fic survival intake